SR ONE CAPITAL MANAGEMENT, LLC
SEC CIK 1853723 · EDGAR
BoughtSold
Most active insiders at ODTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TPG GP A, LLC | Former 10% Owner | $25.00M | — |
| 2 | Li Nan (LN) | Dir | $20.00M | — |
| 3 | Dimension Capital II, L.P. | Dir | $20.00M | — |
| 4 | SR ONE CAPITAL MANAGEMENT, LLC | 10% | $10.00M | $32.0K |
| 5 | Chu Shelley | Dir | $200.0K | — |
| 6 | LEIDEN JEFFREY M | Dir | $100.0K | — |
| 7 | Haas Jason | CFO | $20.0K | — |
| 8 | Opipari Anthony W. | See Remarks | — | — |
| 9 | Glick Gary D | See Remarks, Dir | — | — |
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-05-11 21:11 | 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | C - Cnv Deriv | — | +2.92M | 736.6K | New | — |
| DMI | 2026-05-11 21:11 | 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | X - OptEx | — | +320.0K | 815.3K | +65% | — |
| DMI | 2026-05-11 21:11 | 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | S - Sale+OE | $18.00 | -1,780 | 814.9K | -0.2% | -$32.0K |
| DMI | 2026-05-11 21:11 | 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | P - Purchase | $18.00 | +555.6K | 1.01M | +121% | +$10.00M |
| DMI | 2026-05-01 18:46 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | C - Cnv Deriv | — | +2.75M | 844.3K | New | — |
| DMI | 2026-05-01 18:46 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | P - Purchase | $18.00 | +555.6K | 1.12M | +98% | +$10.00M |
| MI | 2025-10-14 | 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | P - Purchase | $19.00 | +126.3K | 1.17M | +12% | +$2.40M |
| DMI | 2024-09-16 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | C - Cnv Deriv | — | +2.68M | 1.51M | New | — |
| DMI | 2024-09-16 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% | P - Purchase | $17.00 | +2.24M | 1.95M | New | +$38.00M |
Purchase Sale Sale after option exercise All abbreviations